Live Breaking News & Updates on Division Of Rheumatology At Paracelsus Medical University

Stay updated with breaking news from Division of rheumatology at paracelsus medical university. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

UPJOINT: Upadacitinib Demonstrates Efficacy, Safety in Interim Analysis

An interim analysis from the UPJOINT trial provides insight into the effects of upadacitinib use in real-world settings among patients with oligo- or polyarticular psoriatic arthritis. ....

Axel Hueber , Drug Administration , Division Of Rheumatology At Paracelsus Medical University , Paracelsus Medical University , Active Psoriatic Arthritis , Safety Data , Observational Study , Clinical Practice , Activa Psa , Psoriatic Arthritis , Upadacitinib Rinvoq ,